SMTL ID : 2i4h.1

Structural studies of protein tyrosine phosphatase beta catalytic domain co-crystallized with a sulfamic acid inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.15 Å

Oligo State

monomer

Ligands

1 x MG: MAGNESIUM ION(Non-functional Binders)

MG.1: 0 residues within 4Å: (No contacts) No protein-ligand interaction detected (PLIP)

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 1 residues within 4Å: Chain A: R.310 Ligand excluded by PLIP

1 x UA1: N-(TERT-BUTOXYCARBONYL)-L-TYROSYL-N-METHYL-4-(SULFOAMINO)-L-PHENYLALANINAMIDE(Non-covalent)

UA1.3: 15 residues within 4Å: Chain A: R.72, Y.73, N.74, N.75, I.76, D.210, H.211, C.244, S.245, A.246, G.247, V.248, G.249, R.250, Q.288 22 PLIP interactions: 22 interactions with chain A Hydrophobic interactions: A:Y.73, A:Y.73, A:N.75, A:I.76, A:A.246, A:V.248 Hydrogen bonds: A:N.74, A:N.75, A:N.75, A:D.210, A:H.211, A:S.245, A:A.246, A:G.247, A:V.248, A:G.249, A:R.250 Water bridges: A:H.211, A:H.211, A:Q.292 Salt bridges: A:R.250 pi-Cation interactions: A:H.211

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Evdokimov, A.G. et al., Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery. Acta Crystallogr.,Sect.D (2006)

Release Date

2006-08-29

Peptides

Receptor-type tyrosine-protein phosphatase beta: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Receptor-type tyrosine-protein phosphatase beta

Related Entries With Identical Sequence